American Diabetes Association, American Medical Association, Centers for Disease Control and Prevention and the Ad Council launch new creative awareness effort aimed at reducing the incidence of type 2 diabetes New York, NY–(ENEWSPF)–July 25, 2017. Building on a successful campaign that helped hundreds of thousands of Americans learn their risk[Read More…]
Health and Fitness
Bird Songs Provide Insight Into How Developing Brain Forms Memories
UChicago study of zebra finches could help understand human development, autism CHICAGO–(ENEWSPF)–July 24, 2017 By: Thomas Gaulkin Researchers at the University of Chicago have demonstrated, for the first time, that a key protein complex in the brain is linked to the ability of young animals to learn behavioral patterns from[Read More…]
NCI-COG Pediatric MATCH Trial to Test Targeted Drugs in Childhood Cancers
Bethesda, Maryland–(ENEWSPF)–July 24, 2017. Today investigators at the National Cancer Institute (NCI) and the Children’s Oncology Group (COG) announced the opening of enrollment for a unique precision medicine clinical trial. NCI-COG Pediatric Molecular Analysis for Therapy Choice (Pediatric MATCH) is a nationwide trial to explore whether targeted therapies can be[Read More…]
Child Living with HIV Maintains Remission Without Drugs Since 2008
Child treated in infancy as part of NIH-funded study. Bethesda, Maryland–(ENEWSPF)–July 24, 2017. A nine-year-old South African child who was diagnosed with HIV infection at one month of age and received anti-HIV treatment during infancy has suppressed the virus without anti-HIV drugs for eight and a half years, scientists reported[Read More…]
Social Interaction Affects Cancer Patients’ Response to Treatment
Biological basis is unknown but may be related to stress response, NIH researchers say. Bethesda, Maryland–(ENEWSPF)–July 21, 2017. How well cancer patients fared after chemotherapy was affected by their social interaction with other patients during treatment, according to a new study by researchers at the National Human Genome Research Institute[Read More…]
Mayor Emanuel Announces Chicago’s Opioid Addiction Treatment Expansion
Investments in overdose antidote reversed approximately 1,500 overdoses last year, $700K investment will provide treatment for 1,000 residents of South and West Sides CHICAGO—(ENEWSPF)–July 21, 2017. Mayor Rahm Emanuel announced progress and investments in the City’s ongoing efforts to combat the opioid epidemic and improve health. Building on the success[Read More…]
FDA Clears First Neonatal Magnetic Resonance Imaging Device
Silver Spring, Maryland–(ENEWSPF)–July 21, 2017. Today, the U.S. Food and Drug Administration cleared the first magnetic resonance imaging (MRI) device specifically for neonatal brain and head imaging in neonatal intensive care units (NICU). “Although we can use traditional MRI scanners to image neonates, taking babies outside of the neonatal intensive[Read More…]
Center for American Progress Releases State-by-State Medicaid Enrollment by Age, Gender, Race, Ethnicity
Washington, D.C. —(ENEWSPF)–July 20, 2017. Dismantling the Medicaid program is at the heart of President Donald Trump and congressional Republicans’ agenda—and the devastating Medicaid cuts proposed in their attempts to repeal the Affordable Care Act are a critical flashpoint in health care negotiations. President Trump has proposed cutting Medicaid by half in his budget. Yet new analysis from[Read More…]
#TimStrong: Officer Tim Jones Inaugural First Responders Street Dance
Park Forest, IL-(ENEWSPF)- The Park Forest American Legion will hold a street dance fundraiser to benefit Officer Tim Jones. The event will take place on Saturday, August 12, 2017 at 1631 South Western Avenue, Chicago Heights. The Officer Timothy Jones Inaugural First Responders Street Dance will begin at 9:00 a.m.[Read More…]
FDA Approves Vosevi for Treatment of Hepatitis C
Solver Spring, Maryland–(ENEWSPF)–July 18, 2017. The U.S. Food and Drug Administration today approved Vosevi to treat adults with chronic hepatitis C virus (HCV) genotypes 1-6 without cirrhosis (liver disease) or with mild cirrhosis. Vosevi is a fixed-dose, combination tablet containing two previously approved drugs – sofosbuvir and velpatasvir – and[Read More…]
